Literature DB >> 17205476

Escape from immune surveillance by Capnocytophaga canimorsus.

Hwain Shin1, Manuela Mally, Marina Kuhn, Cecile Paroz, Guy R Cornelis.   

Abstract

Capnocytophaga canimorsus, a commensal bacterium from dogs' mouths, can cause septicemia or meningitis in humans through bites or scratches. Here, we describe and characterize the inflammatory response of human and mouse macrophages on C. canimorsus infection. Macrophages infected with 10 different strains failed to release tumor necrosis factor (TNF)- alpha and interleukin (IL)-1 alpha . Macrophages infected with live and heat-killed (HK) C. canimorsus 5 (Cc5), a strain isolated from a patient with fatal septicemia, did not release IL-6, IL-8, interferon- gamma , macrophage inflammatory protein-1 beta , and nitric oxide (NO). This absence of a proinflammatory response was characterized by the inability of Toll-like receptor (TLR) 4 to respond to Cc5. Moreover, live but not HK Cc5 blocked the release of TNF- alpha and NO induced by HK Yersinia enterocolitica. In addition, live Cc5 down-regulated the expression of TLR4 and dephosphorylated p38 mitogen-activated protein kinase. These results highlight passive and active mechanisms of immune evasion by C. canimorsus, which may explain its capacity to escape from the host immune system.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17205476     DOI: 10.1086/510243

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  32 in total

1.  New iron acquisition system in Bacteroidetes.

Authors:  Pablo Manfredi; Frédéric Lauber; Francesco Renzi; Katrin Hack; Estelle Hess; Guy R Cornelis
Journal:  Infect Immun       Date:  2014-11-03       Impact factor: 3.441

Review 2.  Complementary Tolls in the periodontium: how periodontal bacteria modify complement and Toll-like receptor responses to prevail in the host.

Authors:  Jennifer L Krauss; Jan Potempa; John D Lambris; George Hajishengallis
Journal:  Periodontol 2000       Date:  2010-02       Impact factor: 7.589

Review 3.  Toll gates to periodontal host modulation and vaccine therapy.

Authors:  George Hajishengallis
Journal:  Periodontol 2000       Date:  2009       Impact factor: 7.589

Review 4.  Capnocytophaga canimorsus: an emerging cause of sepsis, meningitis, and post-splenectomy infection after dog bites.

Authors:  T Butler
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-04-01       Impact factor: 3.267

5.  Complete genome sequence of the dog commensal and human pathogen Capnocytophaga canimorsus strain 5.

Authors:  Pablo Manfredi; Marco Pagni; Guy R Cornelis
Journal:  J Bacteriol       Date:  2011-10       Impact factor: 3.490

6.  NMR-based structural analysis of the complete rough-type lipopolysaccharide isolated from Capnocytophaga canimorsus.

Authors:  Ulrich Zähringer; Simon Ittig; Buko Lindner; Hermann Moll; Ursula Schombel; Nicolas Gisch; Guy R Cornelis
Journal:  J Biol Chem       Date:  2014-07-02       Impact factor: 5.157

7.  Molecular characterization of Capnocytophaga canimorsus and other canine Capnocytophaga spp. and assessment by PCR of their frequencies in dogs.

Authors:  Alje P van Dam; Angela van Weert; Celine Harmanus; K Emiel Hovius; Eric C J Claas; Frans A G Reubsaet
Journal:  J Clin Microbiol       Date:  2009-07-29       Impact factor: 5.948

8.  Capnocytophaga canimorsus a novel pathogen for joint arthroplasty.

Authors:  A Noelle Larson; Raymund R Razonable; Arlen D Hanssen
Journal:  Clin Orthop Relat Res       Date:  2008-12-09       Impact factor: 4.176

9.  Genetic tools for studying Capnocytophaga canimorsus.

Authors:  Manuela Mally; Guy R Cornelis
Journal:  Appl Environ Microbiol       Date:  2008-08-22       Impact factor: 4.792

10.  Resistance of Capnocytophaga canimorsus to killing by human complement and polymorphonuclear leukocytes.

Authors:  Hwain Shin; Manuela Mally; Salome Meyer; Chantal Fiechter; Cécile Paroz; Ulrich Zaehringer; Guy R Cornelis
Journal:  Infect Immun       Date:  2009-03-23       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.